HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Poh-Yi Gan Selected Research

Toll-Like Receptors (Toll-Like Receptor)

4/2011Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis.
12/2010Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Poh-Yi Gan Research Topics

Disease

18Glomerulonephritis
01/2020 - 06/2010
10Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2021 - 06/2010
4Vasculitis (Vasculitides)
02/2016 - 04/2011
3Infections
06/2019 - 12/2010
3Autoimmune Diseases (Autoimmune Disease)
01/2018 - 01/2015
3Hypersensitivity (Allergy)
12/2012 - 06/2010
2COVID-19
01/2022 - 01/2021
2Necrosis
01/2020 - 03/2013
1Renal Insufficiency (Renal Failure)
01/2019
1Pneumococcal Infections
04/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
04/2016
1Ankylosing Spondylitis
04/2016
1IGA Glomerulonephritis (IGA Nephropathy)
04/2016
1Membranous Glomerulonephritis (Membranous Nephropathy)
04/2016
1Rheumatoid Arthritis
04/2016
1Lupus Nephritis
04/2016
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2016
1Chronic Disease (Chronic Diseases)
04/2016
1Thrombosis (Thrombus)
01/2015
1Nephritis
01/2015
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
05/2014
1Proteinuria
05/2014
1Segmental glomerulosclerosis
05/2014
1Fibrosis (Cirrhosis)
09/2012
1Hemorrhage
12/2010

Drug/Important Bio-Agent (IBA)

16Peroxidase (Myeloperoxidase)IBA
01/2021 - 06/2010
10Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2019 - 04/2011
4CytokinesIBA
11/2019 - 04/2011
4Interleukin-17 (Interleukin 17)IBA
01/2015 - 06/2010
3AntibodiesIBA
04/2018 - 12/2010
3AutoantigensIBA
11/2015 - 06/2010
2Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2014
2Biological ProductsIBA
11/2019 - 04/2016
2EnzymesIBA
11/2015 - 03/2013
2AutoantibodiesIBA
11/2014 - 04/2011
2Toll-Like Receptors (Toll-Like Receptor)IBA
04/2011 - 12/2010
1Peptides (Polypeptides)IBA
01/2022
1BCG VaccineFDA Link
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Interleukin-23 Subunit p19IBA
11/2019
1Interleukin-12 Subunit p35IBA
11/2019
1Monoclonal AntibodiesIBA
11/2019
1Biomarkers (Surrogate Marker)IBA
06/2019
1Immunoglobulins (Immunoglobulin)IBA
06/2019
1HLA Antigens (Human Leukocyte Antigens)IBA
04/2018
1Anaphylatoxin C5a ReceptorIBA
01/2018
1GlucocorticoidsIBA
01/2018
1Complement System Proteins (Complement)IBA
01/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2017
1Interleukin-10 (Interleukin 10)IBA
05/2016
1EpitopesIBA
02/2016
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
02/2016
1Myeloblastin (Proteinase 3)IBA
01/2015
1Urea (Carbamide)FDA LinkGeneric
01/2015
1Mast Cell StabilizersIBA
09/2012
1FibrinIBA
09/2011
1Interleukin-12 (IL 12)IBA
09/2011
1LigandsIBA
04/2011
1Toll-Like Receptor 2IBA
04/2011
1Toll-Like Receptor 9IBA
04/2011
1Transcription Factors (Transcription Factor)IBA
03/2011

Therapy/Procedure

2Therapeutics
01/2018 - 04/2016
2Ligation
09/2012 - 04/2011
1Intraperitoneal Injections
05/2014